Gupta and collaborators demonstrated a link between PTEN and PI3K pathway activation and the response of human lymphoma cell lines to hexavalent antibodies (HexAbs) (anti-CD20, anti-CD22 and anti-CD22-20). The gene discussed is PTEN; the disease is lymphoma.